ArticleJACC. Case reports2025
Implementation of an Elective PCI Patient Risk Assessment and Exclusion Criteria Tool.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNew Jersey amended Cardiac Law (P.L. 2021, c. 18) in 2021, granting cardiac catheterization laboratories without onsite cardiac surgery services licensure to perform non-high risk elective percutaneous intervention (PCI) procedures. Patients considered for elective PCI must undergo careful selection, screening, and risk stratification. PROJECT RATIONALE: Hunterdon Health, a community hospital without onsite cardiac surgery services, recognized the need to establish an elective PCI risk assessment and exclusion criteria tool to be used pre-, intra-, and postprocedure to guide with appropriate patient selection and discharge home the same day of the procedure. PROJECT SUMMARY: Our aim was the implementation of a novel risk tool at the onset of an elective PCI program. We examined the tool's usage and effectiveness in guiding high-risk lesion identification and same-day discharge. TAKE-HOME MESSAGE: A community hospital's cardiac catheterization laboratory licensed for non-high risk elective PCI can safely stratify risk and provide high-quality and safe care to the community that it serves.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.